Total Payments
$299,075
2024 Payments
$26,321
Companies
47
Transactions
829
Medicare Patients
10,842
Medicare Billing
$941,869
Payment Breakdown by Category
Other$260,673 (87.2%)
Travel$19,592 (6.6%)
Food & Beverage$15,240 (5.1%)
Consulting$3,375 (1.1%)
Education$196.17 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $260,673 | 147 | 87.2% |
| Travel and Lodging | $19,592 | 50 | 6.6% |
| Food and Beverage | $15,240 | 623 | 5.1% |
| Consulting Fee | $3,375 | 1 | 1.1% |
| Education | $196.17 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $88,306 | 127 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $51,014 | 223 | $0 (2024) |
| Astellas Pharma US Inc | $35,924 | 37 | $0 (2022) |
| Lilly USA, LLC | $35,763 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $29,108 | 50 | $0 (2022) |
| Amarin Pharma Inc. | $28,883 | 37 | $0 (2020) |
| Esperion Therapeutics, Inc. | $22,956 | 23 | $0 (2022) |
| Ancora Heart, Inc. | $1,755 | 5 | $0 (2022) |
| Abbott Laboratories | $1,027 | 71 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $481.90 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,321 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,884) |
| 2023 | $19,442 | 126 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,690) |
| 2022 | $28,887 | 105 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,876) |
| 2021 | $43,500 | 93 | Esperion Therapeutics, Inc. ($14,773) |
| 2020 | $45,526 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,887) |
| 2019 | $70,891 | 109 | Amarin Pharma Inc. ($20,121) |
| 2018 | $20,914 | 84 | Novartis Pharmaceuticals Corporation ($10,917) |
| 2017 | $43,593 | 141 | Novartis Pharmaceuticals Corporation ($29,525) |
All Payment Transactions
829 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $665.00 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: VTE | ||||||
| 11/01/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: DIABETES | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.35 | General |
| Category: DIABETES | ||||||
| 09/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/10/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,369 | 3,026 | $561,896 | $202,329 |
| 2022 | 32 | 2,586 | 3,224 | $439,899 | $199,306 |
| 2021 | 33 | 3,080 | 3,997 | $668,472 | $298,514 |
| 2020 | 30 | 2,807 | 3,567 | $467,113 | $241,720 |
Total Patients
10,842
Total Services
13,814
Medicare Billing
$941,869
Procedure Codes
143
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 367 | 540 | $106,729 | $44,812 | 42.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 68 | 68 | $68,408 | $21,244 | 31.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 117 | 124 | $45,008 | $14,729 | 32.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 228 | $30,016 | $13,460 | 44.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 151 | $29,121 | $13,225 | 45.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 67 | 133 | $16,625 | $11,737 | 70.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 212 | 218 | $31,577 | $10,999 | 34.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 135 | 139 | $26,833 | $10,734 | 40.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 52 | 208 | $52,000 | $9,164 | 17.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 68 | $22,956 | $8,774 | 38.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 47 | 47 | $14,058 | $5,630 | 40.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 36 | 37 | $8,446 | $4,404 | 52.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 71 | 71 | $13,561 | $3,279 | 24.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 17 | 17 | $7,250 | $2,809 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,802 | $2,509 | 52.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $5,688 | $2,488 | 43.7% |
| 93319 | 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | Facility | 2023 | 134 | 138 | $6,024 | $2,417 | 40.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 26 | 28 | $9,800 | $2,290 | 23.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 80 | 80 | $7,320 | $2,221 | 30.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 206 | 215 | $10,320 | $2,119 | 20.5% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 11 | 11 | $3,785 | $1,865 | 49.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 130 | 132 | $8,388 | $1,706 | 20.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 15 | 19 | $3,860 | $1,453 | 37.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 56 | 58 | $4,204 | $1,399 | 33.3% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 24 | 41 | $2,911 | $1,307 | 44.9% |
About Dr. Vikram Arora, MD
Dr. Vikram Arora, MD is a Cardiovascular Disease healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255335246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Arora, MD has received a total of $299,075 in payments from pharmaceutical and medical device companies, with $26,321 received in 2024. These payments were reported across 829 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($260,673).
As a Medicare-enrolled provider, Arora has provided services to 10,842 Medicare beneficiaries, totaling 13,814 services with total Medicare billing of $941,869. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Birmingham, AL
- Active Since 06/08/2005
- Last Updated 04/18/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255335246
Products in Payments
- JARDIANCE (Drug) $123,926
- ENTRESTO (Drug) $50,388
- Vascepa (Drug) $28,883
- NEXLIZET (Drug) $20,780
- FARXIGA (Drug) $18,949
- LEXISCAN (Drug) $10,767
- LOKELMA (Drug) $9,980
- NEXLETOL (Drug) $2,176
- Lexiscan (Drug) $1,796
- AccuCinch (Device) $1,755
- LEQVIO (Drug) $625.55
- LifeVest (Device) $481.90
- INTELLIS (Device) $465.52
- XARELTO (Drug) $432.03
- MITRACLIP (Device) $403.15
- MitraClip System (Device) $322.54
- Barostim Neo System (Device) $256.55
- ELIQUIS (Drug) $253.28
- UPTRAVI (Drug) $232.42
- BRILINTA (Drug) $213.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Birmingham
Dr. Anil Rajendra, M.d, M.D
Cardiovascular Disease — Payments: $457,890
Cardiovascular Disease $457,890
Robert Bourge, Md, MD
Cardiovascular Disease — Payments: $433,960
Cardiovascular Disease $433,960
Dr. William Maddox, M.d, M.D
Cardiovascular Disease — Payments: $172,753
Cardiovascular Disease $172,753
Dr. Gustavo Morales, Md, MD
Cardiovascular Disease — Payments: $124,880
Cardiovascular Disease $124,880
Thomas Cawthon, M.d, M.D
Cardiovascular Disease — Payments: $105,922
Cardiovascular Disease $105,922
Vera Bittner
Cardiovascular Disease — Payments: $105,808
Cardiovascular Disease $105,808